Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bioventus (BVS) Tax Provisions (2020 - 2025)

Bioventus' Tax Provisions history spans 6 years, with the latest figure at -$3.2 million for Q4 2025.

  • For Q4 2025, Tax Provisions fell 677.27% year-over-year to -$3.2 million; the TTM value through Dec 2025 reached -$1.6 million, up 70.43%, while the annual FY2025 figure was -$1.6 million, 70.43% up from the prior year.
  • Tax Provisions reached -$3.2 million in Q4 2025 per BVS's latest filing, down from $664000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $1.7 million in Q3 2021 to a low of -$29.5 million in Q4 2022.
  • Average Tax Provisions over 5 years is -$2.7 million, with a median of -$84000.0 recorded in 2021.
  • Peak YoY movement for Tax Provisions: surged 1658.18% in 2021, then plummeted 6930.14% in 2022.
  • A 5-year view of Tax Provisions shows it stood at -$2.7 million in 2021, then tumbled by 302.31% to -$11.0 million in 2022, then surged by 93.16% to -$750000.0 in 2023, then skyrocketed by 173.33% to $550000.0 in 2024, then crashed by 677.27% to -$3.2 million in 2025.
  • Per Business Quant, the three most recent readings for BVS's Tax Provisions are -$3.2 million (Q4 2025), $664000.0 (Q3 2025), and $1.0 million (Q2 2025).